Pharmacokinetics of levormeloxifene in young versus elderly postmenopausal women

Clinical Therapeutics

Volumn 23, Issue 1, 2001, Pages 62-71

  Kiehr, Benedicte ^a   Skrumsager, Birte K ^a   Müller, Margarete ^b   Pedersen, Poul C ^a  

^a NOVO NORDISK A S   (Denmark)

^b AAI   (Germany)

Author keywords

Age dependence; Levormeloxifene; Pharmacokinetics; Postmenopausal

Indexed keywords

CENTCHROMAN;

ABDOMINAL PAIN; ADULT; AGED; AGING; AREA UNDER THE CURVE; ARTICLE; BACKACHE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HOT FLUSH; HUMAN; MYALGIA; POSTMENOPAUSE; PRURITUS; VOMITING;

EID: 0035151081     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80030-8     Document Type: Article

References (20)

1. Selective estrogen receptor modulators: A look ahead
2. Levormeloxifene prevents increased bone turnover and trabecular bone loss following ovariectomy in Cynomolgus monkeys
3. Levormeloxifene, a nonsteroidal, partial estrogen agonist, prevents bone loss, reduces serum cholesterol and exerts a nonproliferative action on uterine tissues in the ovariectomized rat
4. A partial estrogen receptor agonist with strong antiatherogenic properties without noticeable effect on reproductive tissue in cholesterol-fed female and male rabbits
5. Levormeloxifene: Escalating single oral doses in healthy postmenopausal women
6. Levormeloxifene, safety and pharmacokinetics after multiple dosing of 56 postmenopausal women
7. Levormeloxifene, a new partial estrogen receptor agonist, demonstrates antiresorptive and antiatherogenic properties in postmenopausal women
8. Metabolism of levormeloxifene, a selective oestrogen receptor modulator, in the Sprague-Dawley rat, Cynomolgus monkey and postmenopausal woman
9. Recommendations guiding physicians in biomedical research involving human subjects
10. Assay for levormeloxifene, a selective estrogen receptor modulator, in human and monkey plasma employing high-performance liquid chromatography and solid-phase extraction
11. Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications
12. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis
13. Pharmacokinetics of drugs in the elderly
14. In vivo age-related changes in hepatic drug-oxidizing capacity in humans
15. Altered pharmacokinetics in the elderly
16. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I)
17. Hepatic drug metabolism and aging
18. Plasma protein binding: An iterative approach of performing equilibrium dialysis
19. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat